Background. Epigenetic modifications have been revealed to play an important role in
tumorigenesis and tumor development. This study aims to analyze the role of histone …

Traditional pathological diagnoses and clinical methods are insufficient to accurately predict
the prognosis of lung adenocarcinoma (LUAD). Epithelial-mesenchymal transition (EMT) …

Background Accumulating evidence has highlighted the significance of chromatin regulator
(CR) in pathogenesis and progression of cancer. However, the prognostic role of CRs in …

Background Lung adenocarcinoma (LUAD) has a complex tumor heterogeneity. Our
research attempts to clearness LUAD subtypes and build a reliable prognostic signature …

A more accurate prognosis is important for clinical treatment of lung adenocarcinoma.
However, due to the limitation of sample and technical bias, most prognostic signatures …

Accumulating evidence has demonstrated that chromatin regulators (CRs) regulate immune
cell infiltration and are correlated with prognoses of patients in some cancers. However, the …

Background Lung adenocarcinoma (LUAD) has become the most frequent histologic type of
lung cancer in the past several decades. Recent successes with immune checkpoint …

Purpose Lung adenocarcinoma (LUAD) is the predominant subtype of lung cancer, with
increasing evidence showing clinical benefits of immunotherapy. However, a lack of …

Immunogenic cell death (ICD) is a type of regulated cell death that is enough to primes
adaptive immune response. Mounting evidence has demonstrated that ICD has the potential …

Considering the key role of myeloid cell differentiation—related genes in the tumor
microenvironment (TME), we aimed to build a prognostic risk model using these genes for …